CLASS II Device recall · Reported 9 Aug 2017 · FDA Enforcement Report

InflammaDry(R) AN Rps Diagnostic Solution recalled by Quidel

Quidel is recalling InflammaDry(R) AN Rps Diagnostic Solution, Sample Collectors InflammaDry(R) is a rapid, distributed nationwide in the US. The recall was initiated on 22 Jun 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot numbers: 1705405, 1705359
Quantity recalled1078 kits, 21,560 sample collectors

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2803-2017
FDA event ID
77640
Recalling firm
Quidel, San Diego, CA
Classification
Class II
Status
Terminated
Recall initiated
22 Jun 2017
FDA classified
1 Aug 2017
Reported
9 Aug 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Foreign Material

Timeline

22 Jun 2017Recall initiated by company
1 Aug 2017Classified by FDA+40 days
9 Aug 2017Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

In-house testing revealed the presence of plastic spurs at the tips of some Sample Collectors.

Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.

Product as listed by the FDA

InflammaDry(R) AN RPS DIAGNOSTIC SOLUTION, Sample Collectors InflammaDry(R) is a rapid, immunoassay test for the visual, qualitative, in vitro detection of elevated levels of the MMP-9 protein in human tears, from patients suspected of having dry eye. InflammaDry is to be used to aid in the diagnosis of dry eye, in conjunction with other methods of clinical evaluation. This test is intended for prescription use at point-of-care sites.

Where it was distributed

Nationwide Distribution including AR, AZ, CA, CO, CT, FL, GA, IL, IN, KY, LA, MA, MD, MI, MN, MO, NC, NE, NH, NJ, NY, OH, OK, PA, SC, SD, TX, VA, WA, & WV.

Nationwide ArkansasArizonaCaliforniaColoradoConnecticutFloridaGeorgiaIllinoisIndianaKentuckyLouisianaMassachusettsMarylandMichiganMinnesotaMissouriNorth CarolinaNebraskaNew HampshireNew Jersey

Questions about this recall

Is InflammaDry(R) AN Rps Diagnostic Solution, Sample Collectors InflammaDry(R) is a rapid recalled?

Yes. Quidel recalled InflammaDry(R) AN Rps Diagnostic Solution, Sample Collectors InflammaDry(R) is a rapid on 22 Jun 2017. The recall is Class II and its status is Terminated. Recall number Z-2803-2017.

Why was it recalled?

In-house testing revealed the presence of plastic spurs at the tips of some Sample Collectors.

Which lots are affected?

Lot numbers: 1705405, 1705359

Where was it sold?

Nationwide Distribution including AR, AZ, CA, CO, CT, FL, GA, IL, IN, KY, LA, MA, MD, MI, MN, MO, NC, NE, NH, NJ, NY, OH, OK, PA, SC, SD, TX, VA, WA, & WV.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Quidel

All 14

Other Test Kits & Diagnostics recalls

All 2,656